HepG2 cells acquire stem cell-like characteristics after immune cell stimulation

C. Geissler, M. Hambek, M. Leinung, M. Diensthuber, D. Gassner, T. Stover, J. Wagenblast, The challenge of tumor heterogeneity--different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model. In Vivo 26, 593–598 (2012)

L.L. Marotta, K. Polyak, Cancer stem cells: a model in the making. Curr. Opin. Genet. Dev. 19, 44–50 (2009)

L.H. Broersen, G.W. van Pelt, R.A. Tollenaar, W.E. Mesker, Clinical application of circulating tumor cells in breast cancer. Cell. Oncol. 37, 9–15 (2014)

J. Di, T. Duiveman-de Boer, P.L. Zusterzeel, C.G. Figdor, L.F. Massuger, R. Torensma, The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cell. Oncol. 36, 363–374 (2013)

A. Koren, H. Motaln, T. Cufer, Lung cancer stem cells: a biological and clinical perspective. Cell. Oncol. 36, 265–275 (2013)

A. Azvolinsky, Companies hope for rare win with cancer stem cell therapies. Nat. Med. 18, 474 (2012)

S. Bhattacharyya, K.L. Khanduja, New hope in the horizon: cancer stem cells. Acta Biochim Biophys Sin (Shanghai) 42, 237–242 (2010)

A. Krishnan, K. Reckamp, L. Leong, City of hope cancer center hematology-oncology fellowship and hematopoietic stem cell transplantation fellowship. Am. J. Hematol. 86, 197–198 (2011)

D.Q. Liu, X.T. Pei, Hope to the cancer therapy: cancer stem cell. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 27, 659–661 (2005)

A.K. Saxena, D. Singh, J. Gupta, Role of stem cell research in therapeutic purpose--a hope for new horizon in medical biotechnology. J. Exp. Ther. Oncol. 8, 223–233 (2010)

R.C. Zhao, Y.S. Zhu, Y. Shi, New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells. Pharmacol. Ther. 119, 74–82 (2008)

P.B. Gupta, C.L. Chaffer, R.A. Weinberg, Cancer stem cells: mirage or reality? Nat. Med. 15, 1010–1012 (2009)

D. Bonnet, J.E. Dick, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730–737 (1997)

H.C. Hasselbalch, Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development? Leuk. Res. 37, 214–220 (2013)

S. Moossavi, H. Zhang, J. Sun, N. Rezaei, Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer. Expert. Rev. Clin. Immunol. 9, 409–422 (2013)

F. Karimi-Busheri, V. Zadorozhny, D.L. Shawler, H. Fakhrai, The stability of breast cancer progenitor cells during cryopreservation: maintenance of proliferation, self-renewal, and senescence characteristics. Cryobiology 60, 308–314 (2010)

S. Varghese, R. Whipple, S.S. Martin, H.R. Alexander, Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis. PLoS One 7, e52825 (2012)

T. Balog, A. Saric, S. Sobocanec, B. Kusic, T. Marotti, Endomorphin-suppressed nitric oxide release from mice peritoneal macrophages. Neuropeptides 44, 25–29 (2010)

Y. Chang, Y. Zhao, H. Zhan, X. Wei, T. Liu, B. Zheng, Bufalin inhibits the differentiation and proliferation of human osteosarcoma cell line hMG63-derived cancer stem cells. Tumour Biol. 35, 1075–1082 (2013)

O. Felthaus, T. Ettl, M. Gosau, O. Driemel, G. Brockhoff, A. Reck, K. Zeitler, M. Hautmann, T.E. Reichert, G. Schmalz, C. Morsczeck, Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. Biochem. Biophys. Res. Commun. 407, 28–33 (2011)

M. Hensel, A. Schneeweiss, H.P. Sinn, G. Egerer, M. Kornacker, E. Solomayer, R. Haas, G. Bastert, A.D. Ho, Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support. Stem Cells 20, 32–40 (2002)

E.D. Hsi, S.H. Jung, R. Lai, J.L. Johnson, J.R. Cook, D. Jones, S. Devos, B.D. Cheson, L.E. Damon, J. Said, Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a cancer and leukemia group B 59909 correlative science study. Leuk. Lymphoma 49, 2081–2090 (2008)

H. Ohata, T. Ishiguro, Y. Aihara, A. Sato, H. Sakai, S. Sekine, H. Taniguchi, T. Akasu, S. Fujita, H. Nakagama, K. Okamoto, Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Cancer Res. 72, 5101–5110 (2012)

D. Ponti, A. Costa, N. Zaffaroni, G. Pratesi, G. Petrangolini, D. Coradini, S. Pilotti, M.A. Pierotti, M.G. Daidone, Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65, 5506–5511 (2005)

M. Salerno, S. Avnet, G. Bonuccelli, A. Eramo, R. De Maria, M. Gambarotti, G. Gamberi, N. Baldini, Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int. J. Oncol. 43, 95–102 (2013)

M.F. Shi, J. Jiao, W.G. Lu, F. Ye, D. Ma, Q.G. Dong, X. Xie, Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell. Mol. Life Sci. 67, 3915–3925 (2010)

Y. Chen, D. Yu, H. Zhang, H. He, C. Zhang, W. Zhao, R.G. Shao, CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int. J. Biol. Sci. 8, 992–1004 (2012)

V.S. Donnenberg, A.D. Donnenberg, Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol. 45, 872–877 (2005)

F. Jin, H.S. Li, L. Zhao, Y.J. Wei, H. Zhang, Y.J. Guo, R. Pang, X.B. Jiang, H.Y. Zhao, Expression of anti-apoptotic and multi-drug resistance-associated protein genes in cancer stem cell isolated from TJ905 glioblastoma multiforme cell line. Zhonghua Yi Xue Za Zhi 88, 2312–2316 (2008)

H. Yi, H.J. Cho, S.M. Cho, K. Jo, J.A. Park, S.H. Lee, B.J. Chang, J.S. Kim, H.C. Shin, Effect of 5-FU and MTX on the expression of drug-resistance related cancer stem cell markers in non-small cell lung cancer cells. Korean J Physiol Pharmacol 16, 11–16 (2012)

E.H. Huang, M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, B.M. Boman, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382–3389 (2009)

M.H. Wright, A.M. Calcagno, C.D. Salcido, M.D. Carlson, S.V. Ambudkar, L. Varticovski, Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 10, R10 (2008)

M.R. Garcia Campelo, G. Alonso Curbera, G. Aparicio Gallego, E. Grande Pulido, L.M. Anton Aparicio, Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway. Clin. Transl. Oncol. 13, 77–83 (2011)

K.A. Hassan, L. Wang, H. Korkaya, G. Chen, I. Maillard, D.G. Beer, G.P. Kalemkerian, M.S. Wicha, Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin. Cancer Res. 19, 1972–1980 (2013)

J. Fu, M. Rodova, S.K. Roy, J. Sharma, K.P. Singh, R.K. Srivastava, S. Shankar, GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft. Cancer Lett. 330, 22–32 (2013)

S.N. Tang, J. Fu, D. Nall, M. Rodova, S. Shankar, R.K. Srivastava, Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int. J. Cancer 131, 30–40 (2012)

A.R. Altaba, P. Sanchez, N. Dahmane, Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2, 361–372 (2002)

L.L. Liu, D. Fu, Y. Ma, X.Z. Shen, The power and the promise of liver cancer stem cell markers. Stem Cells Dev. 20, 2023–2030 (2011)

A. Mantovani, A. Sica, Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231–237 (2010)

M. de Magalhaes-Silverman, L. Hammert, B. Lembersky, J. Lister, W. Rybka, E. Ball, High-dose chemotherapy and autologous stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer: hematopoietic tolerance and efficacy. Bone Marrow Transplant. 21, 1207–1211 (1998)

C.A. Foss, J.J. Fox, G. Feldmann, A. Maitra, C. Iacobuzio-Donohue, S.E. Kern, R. Hruban, M.G. Pomper, Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol. Imaging 6, 131–139 (2007)

B. Hennessy, J.A. McCaffrey, P. Daly, P. Browne, M.J. Kennedy, High dose chemotherapy and stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy. Ir. J. Med. Sci. 171, 158–160 (2002)

J.M. Sun, C. Zhang, X.N. Li, Initial screening of binding-peptide of the cell surface marker CD133 of cancer stem cells. Beijing Da Xue Xue Bao 40, 476–479 (2008)

J.Y. Wong, G. Somlo, T. Odom-Maryon, L.E. Williams, A. Liu, D. Yamauchi, A.M. Wu, P. Yazaki, S. Wilczynski, J.E. Shively, S. Forman, J.H. Doroshow, A.A. Raubitschek, Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer. Clin. Cancer Res. 5, 3224s–3231s (1999)

C. Moncharmont, A. Levy, M. Gilormini, G. Bertrand, C. Chargari, G. Alphonse, D. Ardail, C. Rodriguez-Lafrasse, N. Magne, Targeting a cornerstone of radiation resistance: cancer stem cell. Cancer Lett. 322, 139–147 (2012)

S. Ma, K.W. Chan, T.K. Lee, K.H. Tang, J.Y. Wo, B.J. Zheng, X.Y. Guan, Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 6, 1146–1153 (2008)

Y. Liu, Z.P. Han, S.S. Zhang, Y.Y. Jing, X.X. Bu, C.Y. Wang, K. Sun, G.C. Jiang, X. Zhao, R. Li, L. Gao, Q.D. Zhao, M.C. Wu, L.X. Wei, Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J. Biol. Chem. 286, 25007–25015 (2011)

S.H. Lee, H.S. Hong, Z.X. Liu, R.H. Kim, M.K. Kang, N.H. Park, K.H. Shin, TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem. Biophys. Res. Commun. 424, 58–64 (2012)

T.S. Zhu, M.A. Costello, C.E. Talsma, C.G. Flack, J.G. Crowley, L.L. Hamm, X. He, S.L. Hervey-Jumper, J.A. Heth, K.M. Muraszko, F. DiMeco, A.L. Vescovi, X. Fan, Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 71, 6061–6072 (2011)